Despite the evidence suggesting that the TGF-beta signaling pathway is an important tumor suppressor in TGF-beta sensitive cells, overexpression of TGF-beta protein by TGF-beta resistant cancer cells may actually enhance tumorigenicity in certain instances. It has been theorized that the immune system's tumor surveillance function is locally impaired by tumor cell secretion of TGF-beta. In addition to immune suppression, TGF-beta supports local matrix synthesis which may further enhance tumor viability. We investigated the mechanism by which TGF-beta expression is upregulated in transformed and malignant cells. Previously, we have found a perfect correlation between patterns of expression of Hbx and TGF-beta1 by immunohistochemical analysis of liver sections from Hbx- expressing transgenic mice supporting the existence of a direct association between these two proteins. We also demonstrated that Hbx transactivates the TGF-beta1 promoter through specific Egr-1 binding sites. We have further shown that the Egr-1 protein associates with the Hbx protein and that this interaction is required for Hbx to participate in transcriptional regulation of immediate-early genes. These findings suggest that Hbx expression associated with HBV infection induces TGF-beta1 which then contributes to the pathologic conditions associated with HBV infection. We have discovered that cytomegalovirus (CMV) infection induces expression of TGF-beta1. We have demonstrated that two discrete Egr-1 sites are essential for mediating CMV IE2 transactivation of the TGF-beta1 promoter. In vitro binding assays have revealed that IE2 protein binds directly to an Egr-1 protein through the zinc finger domain. The region of the IE2 protein involved in interactions with Egr-1 appears to be located within the C-terminal portion adjacent to the DNA-binding and dimerization domains. We have shown that IE2 activates transcription of TGF-beta1 via direct interaction with the Egr-1 DNA-binding protein, suggesting that transactivation of other IE2 regulated promoters is similarly mediated through this general transcription factor protein.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005617-08
Application #
2463656
Study Section
Special Emphasis Panel (LC)
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Lee, H-J; Yun, C-H; Lim, S H et al. (2007) SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene 26:173-85
Lucas, Philip J; Kim, Seong-Jin; Mackall, Crystal L et al. (2006) Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood 108:2789-95
Kim, Byung-Gyu; Li, Cuiling; Qiao, Wenhui et al. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015-9
Choi, Kyung-Chul; Lee, Youn Sook; Lim, Seunghwan et al. (2006) Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7:1057-65
Zhang, Qiang; Yang, Ximing J; Kundu, Shilajit D et al. (2006) Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther 5:1733-43
Zhang, Qiang; Jang, Thomas L; Yang, Ximing et al. (2006) Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. Prostate 66:235-47
Minguillon, Jordi; Morancho, Beatriz; Kim, Seong-Jin et al. (2005) Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1. J Leukoc Biol 77:748-58
Ryu, Ji-Kan; Song, Sun U; Han, Jee-Young et al. (2005) Establishment of penile fibrosis model in a rat using mouse NIH 3T3 fibroblasts expressing transforming growth factor beta1. Biol Reprod 72:916-21
Kim, Isaac Yi; Kim, Moses M; Kim, Seong-Jin (2005) Transforming growth factor-beta : biology and clinical relevance. J Biochem Mol Biol 38:1-8
Jin, Wook; Kim, Byung-Chul; Tognon, Cristina et al. (2005) The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor. Proc Natl Acad Sci U S A 102:16239-44

Showing the most recent 10 out of 31 publications